肝胆恶性肿瘤的外科治疗
肝胆恶性肿瘤包括肝细胞癌和胆道癌,其发病率和死亡率与就诊时的分期相关。根治性治疗包括手术切除、消融和肝移植,早期患者手术可提供治愈可能。多学科评估对复杂决策至关重要,辅助化疗和放疗的作用尚未明确。
要点
- 早期肝细胞癌理想候选者手术切除效果好,非手术候选者可考虑消融或肝移植。
- 胆道癌根治性治疗为手术切除,选择性肝门部胆管癌新辅助放化疗后肝移植可治愈。
- 常规辅助化疗和放疗作用未确立,但晚期患者辅助治疗可能改善结局。
核心结论
- 肝胆恶性肿瘤的外科治疗结局似乎正在改善。
- 早期疾病手术可提供根治可能,多学科评估对最佳治疗至关重要。
研究设计与样本
- 本文为综述,未报告系统检索范围和研究样本量。
主要发现
- 肝细胞癌理想候选者手术切除结局良好。
- 早期肝细胞癌非手术候选者可考虑消融和肝移植。
- 胆道癌根治性治疗为手术切除。
- 选择性肝门部胆管癌新辅助放化疗后肝移植可治愈。
- 常规辅助化疗和放疗作用未明确确立,但晚期患者辅助治疗可改善结局。
临床怎么用
- 肝细胞癌早期理想候选者首选手术切除,非手术候选者考虑消融或肝移植。
- 胆道癌以手术切除为根治手段,选择性肝门部胆管癌可考虑新辅助放化疗后肝移植。
- 肝胆恶性肿瘤治疗决策需多学科评估以协调最佳治疗。
局限性
- 本文为综述,未报告系统检索策略和纳入研究特征。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Hepatobiliary cancers which include hepatocellular carcinoma (HCC) and biliary tract cancers (i.e., cholangiocarcinoma and gallbladder carcinoma) are associated with significant morbidity and mortality based on the stage of the disease at presentation. With improved screening for hepatobiliary malignancies in patients with risk factors and with widespread use of laparoscopic cholecystectomy, hepatobiliary malignancies, including incidental diagnosis of gallbladder carcinoma, are on the rise. Definitive treatment of hepatobiliary malignancies include surgical resection, ablation, and liver transplantation. However, management of these cancers is challenging due to the complex hepatobiliary anatomy and the need for meticulous perioperative management especially in patients with advanced liver disease. The management and prognosis of hepatobiliary malignancies vary widely based on the stage of presentation, with surgical options providing the possibility of definitive cure in patients presenting with early-stage disease. Surgical resection for HCC results in good outcomes if performed in ideal candidates. For patients with early HCC who are not candidates for surgical resection, ablation and liver transplantation should be considered. Similarly, surgical resection is also the definitive treatment for biliary tract cancers, and liver transplantation can be curative in selected patients with perihilar cholangiocarcinoma after neoadjuvant chemoradiotherapy. The role of routine adjuvant chemotherapy and radiotherapy is not clearly established, but adjuvant therapies can offer better outcomes in patients with advanced disease at presentation. Outcomes of surgical management of hepatobiliary cancers seem to be improving. Given the complex decision-making process involved, multidisciplinary evaluation is essential to provide and coordinate the best treatments for these patients.
引用
- Gunasekaran G, Bekki Y, Lourdusamy V, et al. Surgical Treatments of Hepatobiliary Cancers. Hepatology. 2020. PMID: 32438491. doi:10.1002/hep.31325
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。